Bellerophon Therapeutics Inc (BLPH)
0.056
0.00 (0.00%)
USD |
OTCM |
Jun 03, 13:48
Bellerophon Therapeutics Max Drawdown (5Y): 99.85% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 99.85% |
April 30, 2024 | 99.85% |
March 31, 2024 | 99.85% |
February 29, 2024 | 99.85% |
January 31, 2024 | 99.85% |
December 31, 2023 | 99.85% |
November 30, 2023 | 99.84% |
October 31, 2023 | 99.82% |
September 30, 2023 | 98.46% |
August 31, 2023 | 98.46% |
July 31, 2023 | 98.46% |
June 30, 2023 | 98.46% |
May 31, 2023 | 98.46% |
April 30, 2023 | 98.46% |
March 31, 2023 | 98.46% |
February 28, 2023 | 98.46% |
January 31, 2023 | 98.46% |
December 31, 2022 | 98.46% |
November 30, 2022 | 98.07% |
October 31, 2022 | 98.07% |
September 30, 2022 | 98.07% |
August 31, 2022 | 98.07% |
July 31, 2022 | 98.07% |
June 30, 2022 | 98.07% |
May 31, 2022 | 98.07% |
Date | Value |
---|---|
April 30, 2022 | 97.79% |
March 31, 2022 | 97.79% |
February 28, 2022 | 97.79% |
January 31, 2022 | 97.79% |
December 31, 2021 | 97.79% |
November 30, 2021 | 97.79% |
October 31, 2021 | 97.79% |
September 30, 2021 | 97.79% |
August 31, 2021 | 97.79% |
July 31, 2021 | 97.79% |
June 30, 2021 | 97.79% |
May 31, 2021 | 97.79% |
April 30, 2021 | 97.79% |
March 31, 2021 | 97.79% |
February 28, 2021 | 97.79% |
January 31, 2021 | 97.79% |
December 31, 2020 | 97.79% |
November 30, 2020 | 97.79% |
October 31, 2020 | 97.79% |
September 30, 2020 | 97.79% |
August 31, 2020 | 97.79% |
July 31, 2020 | 97.79% |
June 30, 2020 | 97.79% |
May 31, 2020 | 97.79% |
April 30, 2020 | 97.79% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.08%
Minimum
Jun 2019
99.85%
Maximum
Dec 2023
98.05%
Average
97.79%
Median
Feb 2020
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -75.39 |
Beta (5Y) | 0.7123 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 220.1% |
Historical Sharpe Ratio (5Y) | -0.2981 |
Historical Sortino (5Y) | -0.9292 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.56% |